| Ytd | -18.38% | |
| 1y | -5.76% |
| Open | 76.50 | Prev Close | 76.78 | Low | 74.92 | High | 77.26 | Mkt Cap | 2.18B |
| Vol | 78.10K | Avg Vol | 870.58K | EPS | 4.53 | P/E | 16.62 | Forward P/E | 49.97 |
| Beta | 0.70 | Short Ratio | 5.57 | Inst. Own | 130.27% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-02 | 50-d Avg | 59.27 | 200-d Avg | 64.56 | 1yr Est | 60.73 |
Analysts raised targets for INSP, SECZ, CLF and WAT, while cutting targets for CRDO, CL and TTMI; ra
Freedom Capital Markets analyst Keith Hinton maintains Inspire Medical Systems (NYSE:INSP) with a
On September 18, 2026, Inspire Medical Systems Inc (INSP) shares rose 5.5% to a current price of $76
Hsbc Holdings PLC trimmed its position in shares of Inspire Medical Systems, Inc. (NYSE: INSP) by 68
Medical Systems, American Well and Butterfly Network have been highlighted in this Industry Outlook
Stifel analyst Jonathan Block maintains Inspire Medical Systems (NYSE:INSP) with a Buy and raises
INSP, AMWL and BFLY are positioned to gain from digital health and AI demand despite cybersecurity r
Inspire Medical, Cybin and Aveanna show overbought RSI readings above 70, signaling potential moment
Bank of New York Mellon Corp acquired a new stake in Inspire Medical Systems, Inc. (NYSE: INSP) in t
Inspire (INSP) reported earnings 30 days ago. What's next for the stock?
MINNEAPOLIS, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire),
ADAR1 Capital Management LLC acquired a new stake in Inspire Medical Systems, Inc. (NYSE: INSP) in t
Bank of America Corp DE cut its holdings in shares of Inspire Medical Systems, Inc. (NYSE: INSP) by
Deutsche Bank AG purchased a new stake in shares of Inspire Medical Systems, Inc. (NYSE: INSP) durin
Inspire Medical stock's 39.7% three-month surge is driven by the easing of reimbursement pressures,
Inspire Medical's Inspire V adoption, clinical evidence and underpenetrated OSA market support growt
Medacta Group (OTCMKTS:MEDGF - Get Free Report) and Inspire Medical Systems (NYSE: INSP - Get Free R
ALGT, HMC, INSP, AII and ALL have been added to the Zacks Rank #1 (Strong Buy) List on August 18, 20
Assenagon Asset Management S.A. increased its position in Inspire Medical Systems, Inc. (NYSE: INSP)
Inspire Medical's vast sleep apnea opportunity, rising margins and debt-free balance sheet support p
Inspire Medical raised its 2026 outlook after a Q2 beat, as Inspire V mix and cost control offset we
Inspire Medical shares jumped 28.1% as an earnings beat, raised 2026 guidance and estimate revisions
Amundi trimmed its holdings in Inspire Medical Systems, Inc. (NYSE: INSP) by 29.6% during the undefi
JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and
Mizuho analyst Anthony Petrone maintains Inspire Medical Systems (NYSE:INSP) with a Outperform an
INSP beats second-quarter estimates, raises its 2026 outlook and sees shares jump despite U.S. reimb
Oppenheimer analyst Suraj Kalia upgrades Inspire Medical Systems (NYSE:INSP) from Perform to Outp
Truist Securities analyst Richard Newitter reiterates Inspire Medical Systems (NYSE:INSP) with a
US stocks rose, with Dow Jones gaining 500 points on Tue.Caterpillar Inc (CAT) shares surged 8.3% on
Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a
INSPI beats expectations, raises FY26 guidance. Analysts raise price targets to $59 & $60. Stock
Piper Sandler analyst Adam Maeder maintains Inspire Medical Systems (NYSE:INSP) with a Neutral an
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday'
Baird analyst Mike Polark maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock rose 118.1% to $0.61 during Monday's after-mark
Inspire Medical Systems (NYSE:INSP) lowers FY2026 GAAP EPS guidance from $0.07-$0.62 to $(0.42)-$0.1
Inspire Medical Systems (NYSE:INSP) raises FY2026 Adj EPS guidance from $0.75-$1.25 to $1.05-$1.45 v
Inspire Medical Systems (NYSE:INSP) reported quarterly earnings of $0.14 per share which beat the an
UBS analyst Patrick Wood assumes Inspire Medical Systems (NYSE:INSP) with a Sell rating and lower
Truist Securities analyst Richard Newitter maintains Inspire Medical Systems (NYSE:INSP) with a H
Freedom Capital Markets analyst Keith Hinton initiates coverage on Inspire Medical Systems (NYSE:
Evercore ISI Group analyst Daniel Markowitz downgrades Inspire Medical Systems (NYSE:INSP) from O
JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and
Piper Sandler analyst Adam Maeder downgrades Inspire Medical Systems (NYSE:INSP) from Overweight
The Nasdaq 100 surged past 28,000 during Tuesday morning trading, setting a fresh record as AI-drive
Stifel analyst Jonathan Block maintains Inspire Medical Systems (NYSE:INSP) with a Buy and lowers
RBC Capital analyst Shagun Singh maintains Inspire Medical Systems (NYSE:INSP) with a Sector Perf
Truist Securities analyst Richard Newitter maintains Inspire Medical Systems (NYSE:INSP) with a H
Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a
(Editor’s note: The future prices of benchmark tracking ETFs, and the headline were updated in the s